Clinical Trial

Rare AutoImmune SElf-management Programme Development

Study acronym: RAISE
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 15, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
The rare autoimmune rheumatic diseases (RAIRDs) are life-long multi-system diseases that are life or organ threatening. RAIRDs can impair quality of life similar to chronic diseases such as heart failure. The aim of the study is to explore content and structure of a support programme for people with RAIRDs in focus groups and survey meetings.
Trial Details
NCT Number NCT06642870
Lead Sponsor University of the West of England
Collaborators: University of Leeds
Conditions Systemic Lupus Erthematosus, Systemic Vasculitis, Inflammatory Myositis, Systemic Sclerosis (SSc), ANCA Associated Vasculitis (AAV), Sjogren Syndrome
Enrollment 360 participants
Start Date 2024-10
Primary Completion 2025-10 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2024-10-15